« Back to News

BioMark Diagnostics Receives Clearance from Health Canada to Commence Clinical Trial with Patented Non-Invasive, Urine-Based Assay to Measure Response to Treatment for Lung Cancer

September 9, 2015

Sept 9thBioMark Diagnostics Receives Clearance from Health Canada (PDF)

 

———————————————